ATC code D05

ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D05 is part of the anatomical group D Dermatologicals.[4]

ATC codes
D Dermatologicals
D01 Antifungals for dermatological use
D02 Emollients and protectives
D03 Preparations for treatment of wounds and ulcers
D04 Antipruritics, including antihistamines, anesthetics, etc.
D05 Antipsoriatics
D06 Antibiotics and chemotherapeutics for dermatological use
D07 Corticosteroids, dermatological preparations
D08 Antiseptics and disinfectants
D09 Medicated dressings
D10 Anti-acne preparations
D11 Other dermatological preparations
ATCvet only
QD51 Products for the treatment of claws and hoofs

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD05.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".

D05A Antipsoriatics for topical use
In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".

D05AC Antracen derivatives
D05AC01 Dithranol
D05AC51 Dithranol, combinations

D05AD Psoralens for topical use
D05AD01 Trioxysalen
D05AD02 Methoxsalen

D05AX Other antipsoriatics for topical use
In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
D05AX01 Fumaric acid
D05AX02 Calcipotriol
D05AX03 Calcitriol
D05AX04 Tacalcitol
D05AX05 Tazarotene
D05AX52 Calcipotriol, combinations
D05AX55 Tazarotene and ulobetasol

D05B Antipsoriatics for systemic use
In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".

D05BA Psoralens for systemic use
D05BA01 Trioxysalen
D05BA02 Methoxsalen
D05BA03 Bergapten

D05BB Retinoids for treatment of psoriasis
D05BB01 Etretinate
D05BB02 Acitretin

D05BX Other antipsoriatics for systemic use
In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
D05BX51 Fumaric acid derivatives, combinations

References
  1. "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. "ATC/DDD Index 2022: code D05". WHO Collaborating Centre for Drug Statistics Methodology.
  5. "ATCvet Index 2022: code QD05". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.